Recruiting LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering NCT06865885 Conditions Cardiometabolic Syndrome, Drug Interactions, Glucose Metabolism Disorders, +7 more Locations UC San Diego Altman Clinical and Translational Research Institute — La Jolla, California, United States View Trial Details
